​

Funding Round

Private Equity Round - Prometheus Biosciences

Private Equity Round - Prometheus Biosciences

Investment Firm

Overview

Prometheus Biosciences develops and commercializes pharmaceutical and diagnostic products to help physicians individualize patient care.

Announced Date

Nov 09, 2020

Funding Type

Private Equity

Highlights

Location

United States, North America

Social

Investor Lead

RTW Investments

RTW Investments

RTW Investments is a convertible_note and early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

7

Investor Name
Participant InvestorIrving Investors
Participant InvestorCedars Sinai
Participant InvestorNestlé
Participant InvestorAGI Partners
Participant InvestorPoint72

Round Details and Background

Prometheus Biosciences raised $130000000 on 2020-11-09 in Private Equity Round

Prometheus Biosciences develops and commercializes pharmaceutical and diagnostic products to help physicians individualize patient care.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 28, 2018
Series B - Prometheus Biosciences
-10.1M
Oct 09, 2017
Series A - Prometheus Biosciences
-3.7M
Dec 08, 2022
Post-IPO Equity - Prometheus Biosciences
-500.0M
Jan 07, 2010
Debt Financing - Prometheus Biosciences
-260.0M

Recent Activity

There is no recent news or activity for this profile.